Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Axios
Axios
Health
Caitlin Owens

Another national security issue: China's drug manufacturing

China’s dominance in drug manufacturing is a national security issue, Bloomberg’s Anna Edney reports.

Details: American officials have expressed two concerns:


  • If China ever decided to cut off the flow of drugs and active ingredients, the U.S. (and many other countries) would likely face steep shortages.
  • Safety and quality lapses in Chinese manufacturing also pose a risk to the U.S., including drugs taken by military personnel.

“The national security risks of increased Chinese dominance of the global [active pharmaceutical ingredient] market cannot be overstated,” the Defense Health Agency’s Christopher Priest told an advisory panel last week, per Bloomberg.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.